Ppp with high effectiveness

Two partnerships in the area of transnational health, GAVI Alliance and the Global Fund, provide examples of highly effective PPPs (cf. Beisheim et al. forthcoming; Schaferhoff 2009; Ulbert 2008). While initially criticized for not being effective, the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF), a PPP with the goal to attract, manage, and disburse resources to fight the three aforementioned diseases, is now also reaching an increasing number of people and regions with HIV/AIDS drugs and therapies, tuberculosis therapies, and insecticide-treated nets and malaria treatment. For example, concerning the GF’s output until 2009, 2.5 million people living with HIV/AIDS in the developing world received antiretroviral treatment (ART), 6 million people received a therapy to treat tuberculosis, and 104 million insecticide-nets (ITN) were distributed to prevent malaria. Between 2007 and 2009, the GF’s output was even more impressive.

The GF also tries to measure its impact on morbidity, mortality, and prevalence rates (Global Fund 2007). While the GF has not met all of its initial (and perhaps overly ambitious) targets, it has substantially improved its performance over the years and is becoming more and more effective. Furthermore, the GF is increasing its contribution to the strengthening of national health systems, and it has been successful in disbursing funds relatively quickly and

table 5.3 Output Measurement for Global Fund

Output Indicators

2006

2007

2008

2009

HIV: People on ARV Treatment

770,000

1.4 million

2 million

2.5 million

TB: Cases Treated Under DOTSa

2 million

3.3 million

4.6 million

6 million

Malaria: ITNs Distributed

18 million

46 million

70 million

104 million

a Directly Observed Treatment, Short-course. Sources: Global Fund 2007, 2009, 2010.

in spending only a small proportion (3 percent) of its budget on operational costs. Hence, we rate the Global Fund as highly effective.

 
Source
< Prev   CONTENTS   Source   Next >